Hematology News

Evaluation of blood volume phenotypes may not only guide treatment in HF hospitalization, but may also be cost-effective for patients, according to two posters presented at the virtual Heart Failure Society of America Scientific Meeting.

World Thrombosis Day is observed Oct. 13.

The emergence of multiple documents outlining treatment recommendations for antiphospholipid syndrome between 2018 and 2020 has saved lives, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.

The increasing number of deaths in the United States due to COVID-19 has underscored the need to identify populations at elevated risk for virus-related mortality.

Cardiovascular and hematological risk factors increased the risk for in-hospital mortality by 613% and 336%, respectively, in pediatric patients who had an ischemic stroke.

Pain is one of the most common symptoms of sickle cell disease, and severe pain is the leading cause of ED visits and hospital stays among patients with this disease.

A study conducted in seven sub-Saharan African countries demonstrated an association between malaria and an increased prevalence of anemia among pregnant women, according to findings published in BMC Pregnancy and Childbirth.

COVID-19 antibodies in convalescent plasma began to disappear in donations made 3 to 4 months after symptom onset, according to results of a longitudinal analysis published in Blood.

The NIH has awarded a $1.7 million grant to fund research into potential treatments for hereditary hemorrhagic telangiectasia, a frequently misdiagnosed but potentially life-threatening bleeding disorder.

Two upcoming virtual conferences will focus on the advancement of women in oncology.